Positive Activities for Asian American Cancer Patients and Caregivers

Cancer Clinical Trial

Official title:

Positive Activities for Asian American Cancer Patients and Caregivers

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT05203614
• Other study ID #: 2021-0998
• Secondary ID: NCI-2021-12848
• Status: Recruiting
• Phase: N/A
• Start date: November 30, 2021
• Est. completion date: December 31, 2026

Study information

• Verified date: April 2024
• Source: M.D. Anderson Cancer Center
• Contact: LI Qian
• Phone: (713) 745-8324
• Email: qlu[@]mdanderson.org
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Positive Activities for Asian American Cancer Patients and Caregivers

Description:

Primary Objectives: The overall objective of this project is to design and test the feasibility of two positive activities, household contribution and outside contribution, to increase quality of life in AA cancer patients. Secondary Objectives: Aim 1: To assess the acceptability and feasibility of household and outside contribution positive activities for AAs through a mixed qualitative and exploratory quantitative investigation. Aim 2: To use the qualitative and quantitative data from Aim 1, in collaboration with the mentorship team, AA community members, and clinicians, to develop one or both positive activity intervention(s) (i.e., household or outside contribution) specifically for AA cancer patients.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 60
• Est. completion date: December 31, 2026
• Est. primary completion date: December 31, 2026
• Accepts healthy volunteers: No
• Gender: All
• Age group: 25 Years to 75 Years

Eligibility

Inclusion criteria for patients will be:

• self-identifies as AA,
• males or females ages 25-75 years
• within 1 year of any cancer diagnosis
• actively undergoing systemic therapy (e.g., chemotherapy, radiation)
• able to identify a caregiver (e.g., spouse) who lives in the same household and consents to participate in the study,
• able to read, write, and speak English (i.e., English proficient; EP),
• access to internet, computer/phone, and web browser.

Exclusion criteria for patients will be:

• life expectancy less than 6 months in the opinion of the primary physician,
• inability to stand or walk on their own or other physical limitations that preclude them from participating (3+ on ECOG performance status),
• major thought disorder (e.g., schizophrenia or bipolar [patient records or

Inclusion criteria for caregivers will be:

• identifies as AA,
• patient considers them to be caregiver, -
• EP,
• access to computer/phone, internet, and web browser.

Exclusion criteria for caregivers will be:

• unwilling or unable to participate in the study for any reason,
• under the age of 18.

Related Conditions & MeSH terms

• Cancer

Intervention

Behavioral:
• Household Contribution
Questionnaires
• Outside Contribution
Questionnaires
• Control
Questionnaires

Locations

Country	Name	City	State
United States	M D Anderson Cancer Center	Houston	Texas

Sponsors (2)

Lead Sponsor	Collaborator
M.D. Anderson Cancer Center	National Institutes of Health (NIH)

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Quality of Life Questionnaires(HRQOL & interpersonal well-being )	Hedonic well-being (positive and negative emotions) will be measured using a modified 12-item Affect-Adjective Scale (AAS)42 that includes low-arousal emotion items (e.g., peaceful/serene, dull/bored).	through study completion, an average of 1 year

External Links

•   M D Anderson Cancer Center